$174.17Average Price Target
The highest estimate is 195.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow RGEN. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Show more...
FAQ
What is Repligen stock price today?▼
The current price of RGEN is $114.2 USD — it has increased by +0.39% in the past 24 hours. Watch Repligen stock price performance more closely on the chart.
What is Repligen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Repligen stocks are traded under the ticker RGEN.
Is Repligen stock price growing?▼
RGEN stock has fallen by -4.83% compared to the previous week, the month change is a -16.3% fall, over the last year Repligen has showed a -24.16% decrease.
What is Repligen market cap?▼
Today Repligen has the market capitalization of 6.43B
When is the next Repligen earnings date?▼
Repligen is going to release the next earnings report on May 05, 2026.
What were Repligen earnings last quarter?▼
RGEN earnings for the last quarter are 0.49 USD per share, whereas the estimation was 0.44 USD resulting in a +11.46% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Repligen revenue for the last year?▼
Repligen revenue for the last year amounts to 1.48B USD.
What is Repligen net income for the last year?▼
RGEN net income for the last year is 97.79M USD.
How many employees does Repligen have?▼
As of March 15, 2026, the company has 1,778 employees.
In which sector is Repligen located?▼
Repligen operates in the Health Care sector.
When did Repligen complete a stock split?▼
Repligen has not had any recent stock splits.
Where is Repligen headquartered?▼
Repligen is headquartered in Waltham, US.